Stigmatization caused by hair loss - a systematic literature review.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
13
08
2019
accepted:
07
04
2020
pubmed:
6
10
2020
medline:
19
8
2021
entrez:
5
10
2020
Statut:
ppublish
Résumé
Hair loss is a symptom that can cause stigmatization and severe impairment of quality of life. The aim of this systematic review was to evaluate the literature on stigmatization of hair loss. Using predefined MeSH terms and keywords, a systematic search was performed in the databases MEDLINE (PubMed), EMBASE, PsycINFO and PsycNET. No time restriction was chosen (last update: May 07, 2019; PROSPERO registration number: CRD42019122966). A total of 98 studies were identified, of which eleven were selected for inclusion in this work. The Hairdex, a questionnaire on disease-specific quality of life, was the most frequently used instrument for the quantitative assessment of stigma. The studies were highly heterogeneous and values for stigmatization of androgenetic alopecia varied widely. However, regardless of the pathogenesis, patients with hair loss often suffer from stigmatization which limits their quality of life. Stigmatization of people with visible skin lesions has often been neglected in clinical practice and in daily contact with affected individuals. Studies that specifically address the stigma of hair loss are rare. Further studies are needed to achieve comparability within pathogeneses as well as with other visible dermatoses in order to better understand the enormous psychosocial burden of hair loss.
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1357-1368Informations de copyright
© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
Références
Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U. Vernarbende Alopezien. J Dtsch Dermatol Ges 2018; 16(4): 435-63.
Katoulis AC, Christodoulou C, Liakou AI et al. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges 2015; 13(2): 137-42.
Seth D, Cheldize K, Brown D, Freeman EF. Global burden of skin disease: Inequities and innovations. Curr Dermatol Rep 2017; 6(3): 204-10.
Harth W. Psychosomatik der Kopfhaut. Hautarzt 2017; 68(6): 445-8.
Wolff H, Fischer TW, Blume-Peytavi U. The diagnosis and treatment of hair and scalp diseases. Dtsch Arztebl Int 2016; 113(21): 377-86.
Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol 2017; 77(1): 136-141.e5.
Blumeyer A, Tosti A, Messenger A et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011; 9 (Suppl 6): S1-57.
Trüeb RM, Dias MFRG. Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol 2018; 54(1): 68-87.
Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005; 331(7522): 951-3.
Goffman E. Stigma: Notes on the Management of Spoiled Identity. London: Penguin Books, 1963.
Fischer TW, Schmidt S, Strauss B, Elsner P. Hairdex. Hautarzt 2001; 52(3): 219-27.
Tizek L, Schielein MC, Seifert F et al. Skin diseases are more common than we think: screening results of an unreferred population at the Munich Oktoberfest. J Eur Acad Dermatol Venereol 2019; 33(7):1421-8.
Augustin M, Sommer R, Topp J et al. Umsetzung der WHO Psoriasis-Resolution in die Öffentlichkeit: Ein bundesweites Programm gegen Stigmatisierung bei chronisch sichtbaren Hauterkrankungen. Available from https://www.egms.de/static/de/meetings/dkvf2018/18dkvf411.shtml (Last accessed May 7, 2019).
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097.
Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-12.
National Institute for Health Research (NHS). PROSPERO - International prospective register of systematic reviews. Available form https://www.crd.york.ac.uk/prospero/ (Last accessed May 7, 2019).
vonElm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61(4): 344-9.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19(6): 349-57.
Ziehfreund S, Schuster B, Zink A. Primary prevention of keratinocyte carcinoma among outdoor workers, the general population and medical professionals: a systematic review updated for 2019. J Eur Acad Dermatol Venereol 2019;33(8): 1477-95.
Baati I, Mnif L, Masmoudi J et al. Psychological impact of chemotherapy induced alopecia. Eur Psychiatry 2010; 25: 869.
Temel AB, Bozkurt S, Alpsoy E. Internalized stigma in acne vulgaris, vitiligo and alopecia areata. J Invest Dermatol 2017; 137(10): S197.
Rosman S. Cancer and stigma: experience of patients with chemotherapy-induced alopecia. Patient Educ Couns 2004; 52(3): 333-9.
Trusson D, Pilnick A. The role of hair loss in cancer identity: Perceptions of chemotherapy-induced alopecia among women treated for early-stage breast cancer or ductal carcinoma in situ. Cancer Nurs 2017; 40(2): E9-E16.
Zannini L, Verderame F, Cucchiara G et al. “My wig has been my journey's companion”: perceived effects of an aesthetic care programme for Italian women suffering from chemotherapy-induced alopecia. Eur J Cancer Care (Engl) 2012; 21(5): 650-60.
Gonul M, Cemil BC, Ayvaz HH et al. Comparison of quality of life in patients with androgenetic alopecia and alopecia areata. An Bras Dermatol 2018; 93(5): 651-8.
Kacar SD, Soyucok E, Bagcioglu E et al. The perceived stigma in patients with alopecia and mental disorder: a comparative study. Int J Trichology 2016; 8(3): 135-40.
Sawant N, Chikhalkar S, Mehta V et al. Androgenetic alopecia: quality-of-life and associated lifestyle patterns. Int J Trichology 2010; 2(2): 81-5.
Schmidt S, Fischer TW, Chren MM et al. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001; 144(5): 1038-43.
van Beugen S, Maas J, van Laarhoven AIM et al. Implicit stigmatization-related biases in individuals with skin conditions and their significant others. Health Psychol 2016; 35(8): 861-5.
Freites-Martinez A, Shapiro J, Chan D et al. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol 2018; 154(6): 670-5.
Tanabe Y, Hayashi K, Ideno Y et al. The Internalized Stigma of Mental Illness (ISMI) scale: validation of the Japanese version. BMC Psychiatry 2016; 16.
Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20(1): 53-63.
Russo PM, Fino E, Mancini C et al. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. J Eur Acad Dermatol Venereol 2019; 33(3): 608-11.
Mandt N, Vogt A, Blume-Peytavi U. Differential diagnosis of hair loss in children. J Dtsch Dermatol Ges 2004; 2(6): 399-411.